DCB Funding Opportunities

Funding Opportunity Announcements (FOA)

Title Announcement Number Opening Date Expiration Date Activity Code
Administrative Supplements to Promote Collaborative Activities in Basic Cancer Research (Admin Supp - Clinical Trial Not Allowed) PA-18-852 07/06/2018 08/07/2018 Supp
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed) PAR-18-830 10/07/2018 06/04/2021 R01
Collaborative Activities to Promote Cancer Cachexia Research (Admin Supp - Clinical Trial Not Allowed) PA-18-821 06/07/2018 07/31/2018 Supp
Synthetic Biology for Engineering Applications (R01 - Clinical Trial Optional) PAR-18-434 01/05/2018 09/08/2020 R01
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed) PAR-17-475 10/28/2017 06/28/2020 R21
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) PAR-17-476 10/28/2017 06/28/2020 R01
Biology of Lung, and Head and Neck Preneoplasias (R21) PA-17-460 01/16/2018 01/08/2021 R21
Biology of Lung, and Head and Neck Preneoplasias (R01) PA-17-459 01/05/2018 01/08/2021 R01
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21) PA-17-449 09/16/2017 09/08/2020 R21
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01) PA-17-440 09/05/2017 09/08/2020 R01
HIV/AIDS and the Tumor Niche (R01) RFA-CA-17-030 07/07/2017 08/08/2018 R01
Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratories (U01) PAR-17-207 05/08/2017 02/08/2019 U01
Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01) PAR-17-206 05/08/2017 02/08/2019 U01
Biological Comparisons in Patient-Derived Cancer Models (U01) PAR-16-344 08/14/2016 03/07/2019 U01
Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21) PAR-16-177 09/16/2016 07/17/2019 R21
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01) PAR-17-171 05/05/2017 01/08/2019 R01
Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) PAR-17-244 05/05/2017 05/08/2020 R01
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) PAR-17-245 05/05/2017 05/08/2020 R01
Gene Fusions in Pediatric Sarcomas (R01) PA-16-251 09/05/2016 05/08/2019 R01
Gene Fusions in Pediatric Sarcomas (R21) PA-16-252 09/05/2016 05/08/2019 R21
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21) PA-16-425 12/07/2016 09/08/2019 R21
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01) PA-16-426 12/07/2016 09/08/2019 R01
Inter-organelle Communication in Cancer (R21) PAR-17-204 03/07/2017 01/16/2020 R21
Inter-organelle Communication in Cancer (R01) PAR-17-203 03/07/2017 01/16/2020 R01
Mechanisms of Alcohol-associated Cancers (R21) PA-17-219 5/16/2017 09/08/2020 R21
Mechanisms of Alcohol-associated Cancers (R01) PA-17-220 05/05/2017 09/08/2020 R01
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21) PAR-17-150 04/22/2017 04/05/2019 R21
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01) PAR-17-151 04/22/2017 04/05/2019 R01
The Role of Mobile Genetic Elements in Cancer (R21) PAR-16-226 09/16/2016 09/08/2019 R21
The Role of Mobile Genetic Elements in Cancer (R01) PAR-16-227 09/05/2016 09/08/2019 R01
Metabolic Reprogramming to Improve Immunotherapy (R01) PAR-16-228 09/05/2016 09/08/2019 R01
Metabolic Reprogramming to Improve Immunotherapy (R21) PAR-16-229 09/16/2016 09/08/2019 R21
Neural Regulation of Cancer (R01) PAR-16-245 09/26/2016 06/28/2019 R01
Neural Regulation of Cancer (R21) PAR-16-246 09/26/2016 06/28/2019 R21
Emerging Questions in Cancer Systems Biology (U01) PAR-16-131 05/24/2016 11/24/2018 U01